177 related articles for article (PubMed ID: 23052949)
1. Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness.
Devaud JC; Berger MM; Pannatier A; Marques-Vidal P; Tappy L; Rodondi N; Chiolero R; Voirol P
Intensive Care Med; 2012 Dec; 38(12):1990-8. PubMed ID: 23052949
[TBL] [Abstract][Full Text] [Related]
2. Does the type of parenteral lipids matter? A clinical hint in critical illness.
Devaud JC; Berger MM; Pannatier A; Sadeghipour F; Voirol P
Clin Nutr; 2017 Apr; 36(2):491-496. PubMed ID: 26829880
[TBL] [Abstract][Full Text] [Related]
3. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.
Barrientos-Vega R; Mar Sánchez-Soria M; Morales-García C; Robas-Gómez A; Cuena-Boy R; Ayensa-Rincon A
Crit Care Med; 1997 Jan; 25(1):33-40. PubMed ID: 8989173
[TBL] [Abstract][Full Text] [Related]
4. Propofol infusion and nutritional support.
Mateu-de Antonio J; Barrachina F
Am J Health Syst Pharm; 1997 Nov; 54(21):2515-6. PubMed ID: 9359962
[No Abstract] [Full Text] [Related]
5. Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors.
Devlin JW; Lau AK; Tanios MA
Pharmacotherapy; 2005 Oct; 25(10):1348-52. PubMed ID: 16185179
[TBL] [Abstract][Full Text] [Related]
6. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
7. Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia.
Guay SP; Paquette M; Taschereau A; Girard L; Desgagné V; Bouchard L; Bernard S; Baass A
Atherosclerosis; 2024 May; 392():117489. PubMed ID: 38448342
[TBL] [Abstract][Full Text] [Related]
8. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient.
Sanchez-Izquierdo-Riera JA; Caballero-Cubedo RE; Perez-Vela JL; Ambros-Checa A; Cantalapiedra-Santiago JA; Alted-Lopez E
Anesth Analg; 1998 Jun; 86(6):1219-24. PubMed ID: 9620508
[TBL] [Abstract][Full Text] [Related]
9. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model.
Barr J; Egan TD; Sandoval NF; Zomorodi K; Cohane C; Gambus PL; Shafer SL
Anesthesiology; 2001 Aug; 95(2):324-33. PubMed ID: 11506101
[TBL] [Abstract][Full Text] [Related]
10. Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive care patients: study protocol for a randomized controlled trial.
Soukup J; Selle A; Wienke A; Steighardt J; Wagner NM; Kellner P
Trials; 2012 Aug; 13():135. PubMed ID: 22883020
[TBL] [Abstract][Full Text] [Related]
11. The g.-469G>A polymorphism in the GPIHBP1 gene promoter is associated with hypertriglyceridemia and has an additive effect on the risk conferred by LPL defective alleles.
Guay SP; Gaudet D; Brisson D
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):358-65. PubMed ID: 21978733
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions.
Sinclair R; Schindler T; Lui K; Bolisetty S
BMC Pediatr; 2018 Nov; 18(1):348. PubMed ID: 30404604
[TBL] [Abstract][Full Text] [Related]
13. Effects on cognitive function of propofol medium and long chain lipid emulsion in patients with hepatic encephalopathy.
Yu S; Hu J; Ding L; Yu D
Panminerva Med; 2017 Dec; 59(4):297-301. PubMed ID: 28884566
[TBL] [Abstract][Full Text] [Related]
14. Association of preservative-free propofol use and outcome in critically ill patients.
Haddad S; Tamim H; Memish ZA; Arabi Y
Am J Infect Control; 2011 Mar; 39(2):141-7. PubMed ID: 20888671
[TBL] [Abstract][Full Text] [Related]
15. Propofol sedation substantially increases the caloric and lipid intake in critically ill patients.
Charrière M; Ridley E; Hastings J; Bianchet O; Scheinkestel C; Berger MM
Nutrition; 2017 Oct; 42():64-68. PubMed ID: 28870480
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.
McCollam JS; O'Neil MG; Norcross ED; Byrne TK; Reeves ST
Crit Care Med; 1999 Nov; 27(11):2454-8. PubMed ID: 10579264
[TBL] [Abstract][Full Text] [Related]
17. The effect on serum lipid concentrations of a prolonged infusion of propofol--hypertriglyceridaemia associated with propofol administration.
Eddleston JM; Shelly MP
Intensive Care Med; 1991; 17(7):424-6. PubMed ID: 1774398
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care.
Song D; Hamza MA; White PF; Byerly SI; Jones SB; Macaluso AD
Anesthesiology; 2004 May; 100(5):1072-5. PubMed ID: 15114202
[TBL] [Abstract][Full Text] [Related]
19. Propofol 2% in critically ill patients: effect on lipids.
McLeod G; Dick J; Wallis C; Patterson A; Cox C; Colvin J
Crit Care Med; 1997 Dec; 25(12):1976-81. PubMed ID: 9403745
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Volatile Anesthetic Agents Compared With Standard Intravenous Midazolam/Propofol Sedation in Ventilated Critical Care Patients: A Meta-analysis and Systematic Review of Prospective Trials.
Jerath A; Panckhurst J; Parotto M; Lightfoot N; Wasowicz M; Ferguson ND; Steel A; Beattie WS
Anesth Analg; 2017 Apr; 124(4):1190-1199. PubMed ID: 27828800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
